Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
Baker DL; Schmidt ML; Cohn SL; Maris JM; London WB; Buxton A; Stram D; Castleberry RP; Shimada H; Sandler A; Shamberger RC; Look AT; Reynolds CP; Seeger RC; Matthay KK; The New England Journal Of Medicine, 2010, vol. 363, issue 14, p 1313, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation